Insider Deal: James Cosman Unloaded 12,500 Shares of Brookline Bancorp, Inc. (BRKL); Bb&T Securities Has Upped By $555,840 Its Merck & Co (MRK) Stake

Bb&T Securities Llc increased Merck & Co Inc (MRK) stake by 0.81% reported in 2017Q3 SEC filing. Bb&T Securities Llc acquired 8,685 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Bb&T Securities Llc holds 1.09 million shares with $69.60M value, up from 1.08M last quarter. Merck & Co Inc now has $153.66B valuation. The stock decreased 3.69% or $2.16 during the last trading session, reaching $56.4. About 19.11M shares traded or 51.22% up from the average. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since February 5, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

In a public report filed with the DC-based SEC, we discovered that the Chief Operations Officer of Brookline Bancorp Inc James Cosman, an insider in focus, made a trade for 12,500 shares of the public firm, having a market value of $209,500 U.S. Dollars using an average price per share of $16.8 U.S. Dollars. Presently, he has in hand a total of 32,560 shares or 0.04% of the company’s market capitalization.

Among 23 analysts covering Merck & Co. Inc. (NYSE:MRK), 16 have Buy rating, 0 Sell and 7 Hold. Therefore 70% are positive. Merck & Co. Inc. had 73 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Buy” rating by Piper Jaffray on Friday, July 28. On Monday, October 30 the stock rating was upgraded by Citigroup to “Buy”. The company was maintained on Wednesday, April 12 by Cowen & Co. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, October 30. The rating was downgraded by BMO Capital Markets on Monday, July 18 to “Market Perform”. Credit Suisse maintained the stock with “Neutral” rating in Monday, May 9 report. Jefferies maintained it with “Sell” rating and $5200 target in Monday, July 17 report. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Friday, July 28 by BMO Capital Markets. The firm earned “Outperform” rating on Friday, September 8 by Credit Suisse. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Bank of America on Thursday, October 13.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.01, from 1.07 in 2017Q2. It dived, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Scotia Cap owns 170,831 shares for 0.16% of their portfolio. Private Trust Co Na stated it has 58,943 shares. Waters Parkerson And has 1.57% invested in Merck & Co., Inc. (NYSE:MRK). Northpointe Cap Limited Liability Corporation stated it has 0.76% in Merck & Co., Inc. (NYSE:MRK). Hartford Mgmt holds 25,952 shares or 0.84% of its portfolio. Epoch Inv Ptnrs reported 2.82 million shares. Horizon Kinetics Limited Liability accumulated 48,869 shares. Clean Yield Grp Incorporated owns 43,227 shares for 1.13% of their portfolio. Aviva Public Ltd accumulated 2.19M shares. Northwest Inv Counselors Ltd invested 0.04% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Boston Private Wealth Llc invested in 1.59% or 647,571 shares. Omers Administration Corporation holds 59,900 shares. Manufacturers Life The holds 0.62% or 8.12M shares. Financial Counselors reported 384,233 shares or 1.2% of all its holdings. 22,273 are held by First Foundation Advisors.

Bb&T Securities Llc decreased Zimmer Biomet Hldgs Inc (ZMH) stake by 54,904 shares to 36,751 valued at $4.30 million in 2017Q3. It also reduced Colgate Palmolive Co (NYSE:CL) stake by 12,891 shares and now owns 49,643 shares. Claymore Exchange Trd Fd Tr (GSY) was reduced too.

Brookline Bancorp, Inc. operates as the holding firm for Brookline Bank, Bank Rhode Island, First Ipswich Bank, and Brookline Securities Corp that provide commercial, business, and retail banking services to corporate, municipal, and retail customers. The company has market cap of $1.24 billion. It accepts various deposit products, including demand checking, NOW, savings, money market, and certificate of deposit accounts. It has a 23.89 P/E ratio. The firm also offers loans, such as first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; and loans and leases used to finance equipment used by small businesses.

Among 4 analysts covering Brookline Bancorp (NASDAQ:BRKL), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Brookline Bancorp has $18.0 highest and $12 lowest target. $15.50’s average target is -4.32% below currents $16.2 stock price. Brookline Bancorp had 16 analyst reports since September 3, 2015 according to SRatingsIntel. Compass Point upgraded the shares of BRKL in report on Thursday, October 22 to “Buy” rating. The firm has “Hold” rating given on Tuesday, August 8 by Keefe Bruyette & Woods. The stock has “Hold” rating by Keefe Bruyette & Woods on Thursday, October 19. The company was maintained on Friday, October 13 by Keefe Bruyette & Woods. The stock of Brookline Bancorp, Inc. (NASDAQ:BRKL) earned “Buy” rating by Sandler O’Neill on Thursday, September 3. Sandler O’Neill upgraded the stock to “Buy” rating in Monday, August 21 report. As per Thursday, December 21, the company rating was maintained by Keefe Bruyette & Woods. The firm has “Neutral” rating by Compass Point given on Friday, November 18. The stock has “Hold” rating by Sandler O’Neill on Thursday, October 19. Piper Jaffray initiated Brookline Bancorp, Inc. (NASDAQ:BRKL) on Wednesday, September 16 with “Neutral” rating.